Cargando…

Interleukin-35: A Novel Mediator of Peripheral Tolerance

Interleukin-35 is a potent suppressive cytokine of the IL-12 family. Although other members of the IL-12 family are produced mainly by antigen-presenting cells (APCs), IL-35 is produced by regulatory T (Treg) cells and suppresses cell proliferation. It has been shown to play an important role in man...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgoffe, Greg M., Vignali, Dario A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120654/
http://dx.doi.org/10.1007/978-4-431-54442-5_15
_version_ 1783515022282981376
author Delgoffe, Greg M.
Vignali, Dario A. A.
author_facet Delgoffe, Greg M.
Vignali, Dario A. A.
author_sort Delgoffe, Greg M.
collection PubMed
description Interleukin-35 is a potent suppressive cytokine of the IL-12 family. Although other members of the IL-12 family are produced mainly by antigen-presenting cells (APCs), IL-35 is produced by regulatory T (Treg) cells and suppresses cell proliferation. It has been shown to play an important role in many disease models and has been recently shown to have additional functions aside from inhibition of proliferation, including inducing its own expression in non-Treg cells. In this chapter, we discuss the history and current status of IL-35 biology, as well as suggest where the field might move in the future.
format Online
Article
Text
id pubmed-7120654
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-71206542020-04-06 Interleukin-35: A Novel Mediator of Peripheral Tolerance Delgoffe, Greg M. Vignali, Dario A. A. Cytokine Frontiers Article Interleukin-35 is a potent suppressive cytokine of the IL-12 family. Although other members of the IL-12 family are produced mainly by antigen-presenting cells (APCs), IL-35 is produced by regulatory T (Treg) cells and suppresses cell proliferation. It has been shown to play an important role in many disease models and has been recently shown to have additional functions aside from inhibition of proliferation, including inducing its own expression in non-Treg cells. In this chapter, we discuss the history and current status of IL-35 biology, as well as suggest where the field might move in the future. 2013-05-31 /pmc/articles/PMC7120654/ http://dx.doi.org/10.1007/978-4-431-54442-5_15 Text en © Springer Japan 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Delgoffe, Greg M.
Vignali, Dario A. A.
Interleukin-35: A Novel Mediator of Peripheral Tolerance
title Interleukin-35: A Novel Mediator of Peripheral Tolerance
title_full Interleukin-35: A Novel Mediator of Peripheral Tolerance
title_fullStr Interleukin-35: A Novel Mediator of Peripheral Tolerance
title_full_unstemmed Interleukin-35: A Novel Mediator of Peripheral Tolerance
title_short Interleukin-35: A Novel Mediator of Peripheral Tolerance
title_sort interleukin-35: a novel mediator of peripheral tolerance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120654/
http://dx.doi.org/10.1007/978-4-431-54442-5_15
work_keys_str_mv AT delgoffegregm interleukin35anovelmediatorofperipheraltolerance
AT vignalidarioaa interleukin35anovelmediatorofperipheraltolerance